Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Coping strategies associated with suicidal behaviour in adolescent inpatients with borderline personality disorder.

Knafo A, Guilé JM, Breton JJ, Labelle R, Belloncle V, Bodeau N, Boudailliez B, De La Rivière SG, Kharij B, Mille C, Mirkovic B, Pripis C, Renaud J, Vervel C, Cohen D, Gérardin P.

Can J Psychiatry. 2015 Feb 1;60(2 Suppl 1):S46-54.

2.

Coping skills among adolescent suicide attempters: results of a multisite study.

Mirkovic B, Labelle R, Guilé JM, Belloncle V, Bodeau N, Knafo A, Condat A, Bapt-Cazalets N, Marguet C, Breton JJ, Cohen D, Gérardin P.

Can J Psychiatry. 2015 Feb 1;60(2 Suppl 1):S37-45.

3.

Risk and Protective Factors for Suicidality at 6-Month Follow-up in Adolescent Inpatients Who Attempted Suicide: An Exploratory Model.

Consoli A, Cohen D, Bodeau N, Guilé JM, Mirkovic B, Knafo A, Mahé V, Laurent C, Renaud J, Labelle R, Breton JJ, Gérardin P.

Can J Psychiatry. 2015 Feb 1;60(2 Suppl 1):S27-36.

4.

Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity.

Mirković B, Markelc B, Butinar M, Mitrović A, Sosič I, Gobec S, Vasiljeva O, Turk B, Čemažar M, Serša G, Kos J.

Oncotarget. 2015 Mar 30. [Epub ahead of print]

5.

Toxicity of copper hydroxide, dithianon, fluazinam, tebuconazole and pyraclostrobin to Didymella applanata isolates from Serbia.

Mirković B, Tanović B, Hrustić J, Mihajlović M, Stević M, Delibašić G, Vukša P.

J Environ Sci Health B. 2015;50(3):175-83. doi: 10.1080/03601234.2015.982414.

PMID:
25602150
6.

The current stage of cathepsin B inhibitors as potential anticancer agents.

Kos J, Mitrović A, Mirković B.

Future Med Chem. 2014 Jul;6(11):1355-71. doi: 10.4155/fmc.14.73.

PMID:
25163003
7.

Immunoevasive Aspergillus virulence factors.

Chotirmall SH, Mirkovic B, Lavelle GM, McElvaney NG.

Mycopathologia. 2014 Dec;178(5-6):363-70. doi: 10.1007/s11046-014-9768-y. Epub 2014 Jun 28.

PMID:
24972669
8.

EEG Controlled Ni Lego Robot: Feasibility Study of Sensorimotor Alpha Rhythm Neurofeedback in Children.

Mirković B, Stevanović M, Savić A.

Biomed Tech (Berl). 2013 Sep 7. pii: /j/bmte.2013.58.issue-s1-G/bmt-2013-4161/bmt-2013-4161.xml. doi: 10.1515/bmt-2013-4161. [Epub ahead of print] No abstract available.

PMID:
24042802
9.

Aspergillus-associated airway disease, inflammation, and the innate immune response.

Chotirmall SH, Al-Alawi M, Mirkovic B, Lavelle G, Logan PM, Greene CM, McElvaney NG.

Biomed Res Int. 2013;2013:723129. doi: 10.1155/2013/723129. Epub 2013 Jul 21. Review.

10.

Development of new cathepsin B inhibitors: combining bioisosteric replacements and structure-based design to explore the structure-activity relationships of nitroxoline derivatives.

Sosič I, Mirković B, Arenz K, Stefane B, Kos J, Gobec S.

J Med Chem. 2013 Jan 24;56(2):521-33. doi: 10.1021/jm301544x. Epub 2013 Jan 4.

PMID:
23252745
11.

Three-dimensional invasion of macrophages is mediated by cysteine cathepsins in protrusive podosomes.

Jevnikar Z, Mirković B, Fonović UP, Zidar N, Švajger U, Kos J.

Eur J Immunol. 2012 Dec;42(12):3429-41. doi: 10.1002/eji.201242610. Epub 2012 Nov 7.

PMID:
23018451
12.

Cathepsin H indirectly regulates morphogenetic protein-4 (BMP-4) in various human cell lines.

Rojnik M, Jevnikar Z, Mirkovic B, Janes D, Zidar N, Kikelj D, Kos J.

Radiol Oncol. 2011 Dec;45(4):259-66. doi: 10.2478/v10019-011-0034-3. Epub 2011 Oct 8.

13.

Regulation of cathepsins S and L by cystatin F during maturation of dendritic cells.

Magister S, Obermajer N, Mirković B, Svajger U, Renko M, Softić A, Romih R, Colbert JD, Watts C, Kos J.

Eur J Cell Biol. 2012 May;91(5):391-401. doi: 10.1016/j.ejcb.2012.01.001. Epub 2012 Feb 23.

PMID:
22365146
14.

Redox-based inactivation of cysteine cathepsins by compounds containing the 4-aminophenol moiety.

Mirković B, Sosič I, Gobec S, Kos J.

PLoS One. 2011;6(11):e27197. doi: 10.1371/journal.pone.0027197. Epub 2011 Nov 4.

15.

Discovery and kinetic evaluation of 6-substituted 4-benzylthio-1,3,5-triazin-2(1H)-ones as inhibitors of cathepsin B.

Sosič I, Mirković B, Turk S, Štefaneb B, Kos J, Gobec S.

Eur J Med Chem. 2011 Sep;46(9):4648-56. doi: 10.1016/j.ejmech.2011.08.005. Epub 2011 Aug 9.

PMID:
21849222
16.

Novel mechanism of cathepsin B inhibition by antibiotic nitroxoline and related compounds.

Mirković B, Renko M, Turk S, Sosič I, Jevnikar Z, Obermajer N, Turk D, Gobec S, Kos J.

ChemMedChem. 2011 Aug 1;6(8):1351-6. doi: 10.1002/cmdc.201100098. Epub 2011 May 20. No abstract available.

PMID:
21598397
17.

Differential role of cathepsins B and L in autophagy-associated cell death induced by arsenic trioxide in U87 human glioblastoma cells.

Pucer A, Castino R, Mirković B, Falnoga I, Slejkovec Z, Isidoro C, Lah TT.

Biol Chem. 2010 May;391(5):519-31. doi: 10.1515/BC.2010.050.

PMID:
20302512
18.

Regulation of cathepsin B activity by 2A2 monoclonal antibody.

Mirković B, Premzl A, Hodnik V, Doljak B, Jevnikar Z, Anderluh G, Kos J.

FEBS J. 2009 Sep;276(17):4739-51. doi: 10.1111/j.1742-4658.2009.07171.x. Epub 2009 Jul 27.

PMID:
19656187
19.

Diagnosis of infection with human herpes viruses in routine laboratory practice.

Mostafaie N, Huber KR, Sebesta C, Bauer K, Kristoferitsch W, Volc-Platzer B, Kurz H, Klinghofer I, Mirkovic B, Hofmann J, Hejtman M, Schrattbauer K, Krugluger W.

Clin Chem Lab Med. 2009;47(9):1141-5. doi: 10.1515/CCLM.2009.251.

PMID:
19634984
20.

Survey of CF mutations in the clinical laboratory.

Huber K, Mirkovic B, Nersesian R, Myers A, Saiki R, Bauer K.

BMC Clin Pathol. 2002 Nov 19;2(1):4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk